Abiopharma

MOZAYYX Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (MZYX.W) was added to the exchange traded list on NYSE

FT Vest U.S. Equity Buffer & Digital Return ETF - April (DGAP) was added to the exchange traded list on BATS

Credit Suisse High Yield Credit Fund Rights (expiring May 14, 2026) Rights when issued (DHY.V) was added to the exchange traded list on NYSE MKT

ASND attributes changed: Attr: Sec_name Ascendis Pharma A/S - American Depositary Shares -> Ascendis Pharma A/S - Ordinary Share;

NASDAQ traded attribute type Security_Name was changed. Previous value: Ascendis Pharma A/S - American Depositary Shares. New value: Ascendis Pharma A/S - Ordinary Share.

NASDAQ symbol attribute type Security_Name was changed. Previous value: Ascendis Pharma A/S - American Depositary Shares. New value: Ascendis Pharma A/S - Ordinary Share.

SLNH attributes changed: Attr: Fin_status N -> D;

SKK attributes changed: Attr: Fin_status D -> N;

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

GNTA attributes changed: Attr: Fin_status N -> D;